CD79A and COVID-19: Nevertheless, we believe this study provides valuable information regarding the serological analysis of COVID-19 considering the parameters of gender, age, viral load, comorbidities, and duration of responses for IgM, IgG, IgA, and IgE antibodies in mildly symptomatic patients.